Collectively, these findings illuminate the multifaceted pro-tumorigenic role of IL-33 in breast carcinoma, impacting various aspects of the disease including the tumor tissue, cell proliferation and differentiation, metabolic processes, and immune responses. This evidence concerns the gene IL33 and neoplasm.